The molecular docking study was performed using Schrödinger Small-Molecule Drug Discovery Suite (Schrödinger, LLC, New York, NY, USA). The FGF14:Nav1.6 homology model was built using the FGF13:Nav1.5:CaM ternary complex crystal structure (PDB code: 4DCK) as a template [14 (link)]. The FGF14:Nav1.6 CTD homology model was prepared with Schrödinger Protein Preparation Wizard using default settings. The SiteMap (Schrödinger, LLC) calculation was performed, and a potential binding site was identified on the PPI interface of FGF14 and the CTD of the Nav1.6 channel. The docking was performed on the CTD of Nav1.6 after removing the FGF14 chain structure. The grid center was chosen on the Nav1.6 CTD at the previously identified binding site with a grid box sized in 24 Å covering the PPI surface on the Nav1.6 CTD. The 3D structure of PW201 was created using Schrödinger Maestro and a low-energy conformation was generated using LigPrep. Docking was then employed with Glide using the SP precision. Docked poses were incorporated into Schrödinger Maestro for a ligand–receptor interactions visualization. The top docked pose of PW201 was superimposed with the FGF14:Nav1.6 CTD complex homology model for an overlay analysis.
Free full text: Click here